Drug Approval | January 22, 2025
Kwality Pharmaceuticals receives SFDA GMP approval for 2 units
This certification will open new markets for the Kwality Pharma
This certification will open new markets for the Kwality Pharma
_256_384.jpg)
Mesalazine is used to treat inflammatory bowel disease
He is an experienced professional in the pharmaceutical industry with about 30 years of progressive experience
Immedica to commence a cash tender offer to acquire all issued and outstanding shares of Marinus for an enterprise value of approximately US$ 151 million
The company's portfolio includes 21 commercialized products, 19 approved ANDAs, 4 CGT designations, 6 filed ANDAs, and 45 products in its pipeline
This approval is a significant achievement in expanding the availability of this critical therapeutic,
The transaction is expected to result in approximately $175 million to support further development of IMG-007
Divalproex Sodium Delayed-Release Capsules USP, 125 mg have an estimated market size of US$ 61.1 million for twelve months ending September 2024 according to IQVIA
Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS
The successful completion of RRA assessment by the USFDA, would enable company to open up its business in the USA market
Subscribe To Our Newsletter & Stay Updated
